Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Viral load and ganciclovir (GCV) concentration in cerebrospinal fluid of patients successfully treated with GCV or valGCV for human herpesvirus 6 encephalitis/myelitis following umbilical cord blood transplantation.
Morita D, Hirabayashi K, Katsuyama Y, Morokawa H, Motobayashi M, Kurata T, Shigemura T, Tanaka M, Inaba Y, Koike K, Nakazawa Y. Morita D, et al. Among authors: katsuyama y. Transpl Infect Dis. 2016 Oct;18(5):773-776. doi: 10.1111/tid.12579. Epub 2016 Sep 7. Transpl Infect Dis. 2016. PMID: 27459097
Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid.
Hirabayashi K, Nakazawa Y, Katsuyama Y, Yanagisawa T, Saito S, Yoshikawa K, Shigemura T, Sakashita K, Ichikawa M, Koike K. Hirabayashi K, et al. Among authors: katsuyama y. Infection. 2013 Feb;41(1):219-23. doi: 10.1007/s15010-012-0329-3. Epub 2012 Sep 13. Infection. 2013. PMID: 22971937
Successful induction of therapeutic urinary concentration by intravenous ganciclovir and oral valganciclovir with remission of adenoviral hemorrhagic cystitis after cord blood transplantation.
Yanagisawa T, Saito S, Katsuyama Y, Hirabayashi K, Shigemura T, Tanaka M, Sakashita K, Nakazawa Y. Yanagisawa T, et al. Among authors: katsuyama y. Pediatr Transplant. 2018 Jun 8:e13241. doi: 10.1111/petr.13241. Online ahead of print. Pediatr Transplant. 2018. PMID: 29885009
Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Yoshikawa K, Nakazawa Y, Katsuyama Y, Hirabayashi K, Saito S, Shigemura T, Tanaka M, Yanagisawa R, Sakashita K, Koike K. Yoshikawa K, et al. Among authors: katsuyama y. Infection. 2014 Aug;42(4):639-47. doi: 10.1007/s15010-014-0601-9. Epub 2014 Feb 25. Infection. 2014. PMID: 24567233
Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
Mimura A, Yamaori S, Ikemura N, Katsuyama Y, Matsuzawa N, Ohmori S. Mimura A, et al. Among authors: katsuyama y. J Clin Pharm Ther. 2019 Aug;44(4):565-571. doi: 10.1111/jcpt.12834. Epub 2019 Apr 4. J Clin Pharm Ther. 2019. PMID: 30950099
394 results